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Abstract
Background: Two rodent choroid plexus (CP) epithelial cell lines, Z310 and TR-CSFB, were compared with primary
rat CP epithelial cells and intact CP tissue with respect to transport protein expression, function and tight junction
(TJ) formation.
Methods: For expression profiles of transporters and TJ proteins, qPCR and western blot analysis were used.
Uptake assays were performed to study the functional activity of transporters and TJ formation was measured by
trans-epithelial electrical resistance (TEER) and visualized by electron microscopy.
Results: The expression of known ATP-binding cassette (Abc) transporter and solute carrier (Slc) genes in CP was
confirmed by qPCR. Primary cells and cell lines showed similar, but overall lower expression of Abc transporters
and absent Slc expression when compared to intact tissue. Consistent with this Mrp1, Mrp4 and P-gp protein levels
were higher in intact CP compared to cell lines. Functionality of P-gp and Mrp1 was confirmed by Calcein-AM and
CMFDA uptake assays and studies using [
3H]bis-POM-PMEA as a substrate indicated Mrp4 function. Cell lines
showed low or absent TJ protein expression. After treatment of cell lines with corticosteroids, RNA expression of
claudin1, 2 and 11 and occludin was elevated, as well as claudin1 and occludin protein expression. TJ formation
was further investigated by freeze-fracture electron microscopy and only rarely observed. Increases in TJ particles
with steroid treatment were not accompanied by an increase in transepithelial electrical resistance (TEER).
Conclusion: Taken together, immortalized cell lines may be a tool to study transport processes mediated by P-gp,
Mrp1 or Mrp4, but overall expression of transport proteins and TJ formation do not reflect the situation in intact
CP tissue.
Background
The blood-brain barrier (BBB) and the blood-cerebrosp-
inal fluid (CSF) barrier (BCSFB) protect the brain from
xenobiotics or other harmful molecules and ensure
homeostasis of brain fluids. The BCSFB is formed by
epithelial cells of the choroid plexuses (CP), which are
located in the lateral, third and fourth ventricles [1].
Besides its barrier function, the CP produces and
secretes CSF and supplies the brain with nutrients [2].
The paracellular route is obstructed due to tight junc-
tions (TJs) between epithelial cells. Substance exchange
between blood and CSF is mediated by several transport
proteins, which actively take up certain substrates into
epithelial cells and efflux substances out of the cells. CP
amounts to only 0.25% of the brain [1] due to its small
size (especially in rodents) and in vitro studies using pri-
mary rat CP epithelial cells are time and cost consum-
ing. Therefore, CP cell line models have become
important tools to study different pathological condi-
tions and functions of CP. Two immortalized choroid
plexus cell lines, TR-CSFB [3] and Z310 [4], have been
developed from rat primary epithelial cells by
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terized in this study.
The ATP-binding cassette (Abc) and solute carrier
(Slc) family play an essential role in transportation of a
broad variety of substances and xenobiotics out of the
brain, by uptake from CSF into epithelial cells and sub-
sequent efflux into blood. Certain transporters of those
families are known to be expressed in CP epithelial
cells. Efflux transporters of the Abcc (multidrug resis-
tance-associated protein, Mrp) family are expressed in
CP tissue including Mrp1 [5], Mrp4 [6,7] and Mrp5
[7,8], while expression of P-glycoprotein (P-gp, Abcb1)
m a yb em o r ec o n t r o v e r s i a l .R a oet al. described P-gp
protein expression in rat, mouse and human CP mem-
brane fractions and sub-apical localization in rat CP,
whereas Choudhuri et al. found P-gp RNA hardly to be
expressed by the branched DNA assay method [5,7].
Mrp1 substrates include MK571 and indomethacin
[9]. Mrp4 and Mrp5 show different substrate specifici-
ties than other Mrps, due to different structural charac-
teristics. Substrates of those transporters include cyclic
nucleotides such as cAMP and cGMP and nucleoside
analogs like 9-(2-phosphonylmethoxyethyl)-adenine)
(PMEA, adefovir) [10,11]. Mrp4 is inhibited by dipyrida-
mole, dehydroepiandrosterone sulphate (DHEAS),
MK571, sulindac sulfide, methotrexate and taurocholate
(TC) [12,13]. P-gp is specifically inhibited by PSC833
(Valspodar®), LY335979 and GF120918 [14].
Organic anion transporters (Oats) belong to the Slc22
family. In rat CP epithelial cells Slc22a7 (Oat2) [7,15,16]
and Slc22a8 (Oat3) expression was described previously
[15-17].
Organic anion transporting polypeptides (Oatps) are
members of the Slco/Slc21 family and Slco1a4 (Oatp1a4)
was found to be expressed in rat CP and located on the
basolateral membrane of the epithelial cells [18].
Slco1a5 (Oatp1a5) is abundantly expressed and located
at the brush border membrane [19].
Hitherto, the two immortalized rat CP cell lines TR-
CSFB and Z310 were characterized according to expres-
sion of the typical choroid plexus epithelial cell marker
transthyretin (TTR) [4]. Expression of Na
+/K
+-ATPase,
Mrp1 and Oatp1a5 has been described in TR-CSFB cells
[20]. Functional activity could be demonstrated for
Oatp1a5 by estrone-3-sulfate efflux [21]. In the Z310
cell line, expression of TTR receptor TfR and the trans-
port proteins P-gp, Mrp1, Oat3 and organic cation
transporter (Oct1, Slc22a1) have been described [4].
TJs connect CP epithelial cells and restrict solute
movement through the paracellular pathway. In rodent
CP, TJ proteins claudin1, 2 and 11 and occludin have
been verified [22]. Expression of claudin1 (0.04% of CP),
2, 4, 8 and occludin (70% of CP) as well as its cytosolic
binding partner, zonula occludens (ZO) 1-3, have been
demonstrated in Z310 cells [23]. In TR-CSFB cells
occludin has been found to be expressed at a lower level
than in Z310, while claudin1 had higher expression at
the protein level [24]. Trans-epithelial electrical resis-
tance (TEER) in Z310 cells was enhanced by use of col-
lagen-coated polyester filter membranes and treatment
with glucocorticoids like dexamethasone. The sucrose
permeability coefficient was also decreased [25].
The aim of the current study was to characterize
TR-CSFB and Z310 CP cell lines in respect of the
expression of Abc and Slc transport proteins and the
functionality of the highly expressed transporters P-gp,
Mrp1 and Mrp4. Furthermore, the expression of TJ pro-
teins and TJ formation was investigated.
Methods
Chemicals
Cell culture devices and kits were purchased from the
following companies: Dulbecco’s modified essential
medium (DMEM), DMEM-Ham’s F12, as well as fetal
bovine serum (FBS), Penicillin/Streptomycin, and Kana-
mycin, L-glutamine from Biochrom (Berlin, Germany);
RNeasy kit, qPCR primer and QuantiFast SYBR green
PCR kit from QIAGEN (Hilden, Germany), Comple-
te™EDTA-free; Protease Inhibitor Cocktail Tablets from
Roche (Mannheim, Germany), iScript™RT PCP kit from
Biorad (München, Germany) Antibodies: anti-ABCC1
MAb [MRPr1], anti-p-glycoprotein MAb (C219) were
ordered from Alexis Biochemicals (Lörrach, Germany)
and anti-ABCC4 MAb [M4I-80] was obtained from
Abcam (Dresden, Germany), mouse anti-Occludin and
mouse anti-Claudin1 from Invitrogen (Karlsruhe, Ger-
many). Secondary antibodies: Horseradish peroxidase
conjugated anti-mouse and horseradish peroxidase con-
jugated anti-rat were purchased from Abcam, Western
Lightning® PLUS ECL, Enhanced Chemiluminescence
Substrate, Ultima Gold™, Perkin Elmer (Rodgau, Ger-
many), 25% Glutaraldehyde were obtained from Serva
(Heidelberg, Germany), [
3H]bis-POM-PMEA from Hart-
mann Analytics (Braunschweig, Germany), CellTracker™-
Green CMFDA was purchased from Invitrogen
(Karlsruhe, Germany) and PSC833 was a kind gift from
Novartis Pharma (Basel, Switzerland). All other chemi-
cals were purchased from Sigma-Aldrich (Steinheim,
Germany).
Choroid plexus isolation
All experiments with animals were performed in accor-
dance with German legal authorities and central animal
facility of the University of Heidelberg (TV51/09). Male
Wistar rats (230- 250 g) were cervical dislocated after
isofluoran inhalation and the brains were removed and
dissected in order to remove the CPs from lateral and
third ventricles. CPs were either transferred into
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protease inhibitor for protein isolation.
Cell culture
Detailed information about TR-CSFB and Z310 cultur-
ing can be found in [3] and [4]. Briefly, TR-CSFB and
Z310 cells were grown in DMEM media; TR-CSFB cells
at 33°C and Z310 at 37°C with 95% humidity and 5%
CO2. For TEER measurements 2x 10
5 cells/well were
seeded on collagen-precoated transwell® polyester
membranes.
Primary rat CP cell culture
For primary rat CP cell culture, 10-14 Wistar pups (P2)
were used according to the protocol of Strazielle and
Ghersi- Egea [26]. In brief, lateral CPs were dissected
from each hemisphere and collected in pre-warmed cul-
ture medium (DMEM-Ham’s F12, 10% FBS, 2 mM L-
glutamine, 4 mM kanamycin and 10nM EGF). CPs were
washed in PBS twice and incubated in PBS with 1mg/ml
protease (from Strepoyces griseus) added for 25 min at
37°C while shaking at 300 rpm. Predigested CPs were
allowed to sediment for 5 min and washed with PBS
once. Then the following procedure was repeated three
times: pellets were shaken in 1ml 0.025% trypsin (PBS)
for 5 min at 37°C at 300 rpm, centrifuged for 5 min at
800 × g. Afterwards the pellet was re-suspended in 10
ml of pre-warmed culture medium, seeded to 25cm
2
flasks and incubated at 37°C, 95% humidity and 5%
CO2. After 2 h non-attached cells were taken and
seeded to collagen-coated transwell filters (for TEER
measurement) or 25cm
2 flasks (for RNA isolation).
RNA extraction and qPCR
RNA was extracted either from a 75cm
2 flask of 90% con-
fluent cells or from freshly isolated choroid plexuses dis-
sected from 5-8 Wistar rats by following the RNeasy
protocol. RNA concentration was measured with Nano-
Drop. 1 μg of RNA was converted to cDNA by using
iScript™cDNA synthesis kit. 50ng cDNA were used for
qPCR. All primers were purchased from QIAGEN (Quan-
tiTect Primer Assay: Abcc1: QT01811803, Abcc2:
QT00374038, Abcc3: QT00191716, Abcc4: QT01804040,
Abcc5: QT00179634, Abcc6:QT00188048, Slc22a6:
QT00191261, Slc22a7: QT00177674, Slc22a8:
QT00188937, Slco1a1: QT01084622, Slco1a4:
QT00178815, Slco1a5: QT01829793, Slco2b1:
QT00188489, Slco4a1: QT00193564, Pgp: QT00372673,
Abcg2: QT00173138, Gapdh: QT00199633, Ocln:
QT00196357, Cldn1: QT00399931, Cldn2: QT02356396,
Cldn11: QT00176148) and tested with RNA extracted
either from rat kidney or liver tissue (positive control) if
not expressed in CP. The QuantiTect Primer Assays
g u a r a n t e et ob ea c c u r a t ea n dt ob ea l r e a d yo p t i m i z e d .
http://www.qiagen.com/products/pcr/quantitect/primeras-
says.aspx#Tabs=t1. The following qPCR conditions were
used: amplification 5 min at 95°C, 45 cycles of 10 sec
95°C, 30 sec 60°C and melting curve analysis 15 sec 95°C,
15 sec 65°C and final cooling to 40°C. Quantification cycle
(Cq) values of each gene were normalized to the reference
gene Gapdh (2
ΔCq
GAPDH
-ΔCq
GOI)i ne a c hg r o u p .
Protein extraction
Membrane proteins were extracted according to protocol
[27] with slight modifications. Cells were harvested from
a 175cm
2 flask of 90% confluent cells, centrifuged and
pellets resuspended in 35ml ice-cold hypotonic buffer
(0.5 mM NaH2PO4,0 . 5m MN a 2 PO4,0 . 1m ME D T A ,
pH7) with one tablet of Complete™EDTA free protease
inhibitor cocktail. Then they were shaken for 45 min at
4°C and ultracentrifuged at 100,000 × g at 4°C. Pellets
were resuspended in Tris-sucrose buffer (10 mM Tris-
HEPES, 250 mM sucrose, pH7.4) with 1 tablet Comple-
te™EDTA protease inhibitor and homogenized 30 times
with a Dounce-homogenizer. To remove cell waste, cen-
trifugation was performed for 15 min at 1,000 × g, before
supernatant was used to gain membrane proteins by
ultracentrifugation at 100,000 × g at 4°C for 1 h. Finally,
the pellet was re-suspended in 500 μl Tris-sucrose buffer
and protein concentrations were measured by Bradford
protein assay [28]. Freshly isolated lateral CPs of 5 Wistar
rats were used to extract whole protein following the Cel-
Lytic™protocol. In brief, CPs were collected in 1ml CelLy-
tic™reagent containing 1:50 protease inhibitor on ice and
stirred for 1 h. Centrifugation was performed for 10 min
at 12,000 × g at 4°C; supernatant contained proteins.
Western blot
Bio-Rad (München, Germany) system was used for
immunoblot analysis. Proteins (10 μg) were diluted in 5x
sample buffer (25%Gycerol, 7.5% SDS, 337 mM Tris, add
freshly: 250 mM DTT, 0.25% bromphenol blue) and
denatured at 95°C for 5 min. According to protein size
8-15% SDS gels were used; for Mrp1, 4 and P-gp: 10%,
for claudin1: 15% and for occludin: 8%. Immunoblotting
was performed for 1 h at 250mA and blocking for
30 min. Primary antibodies were added in an 1:100 (anti-
Mrp1, anti-Mrp4, anti-P-gp) or 1:250 (anti-claudin1,
anti-occludin, anti-Na
+/K
+-ATPase) dilution in blocking
solution (5% milk) and incubated overnight at 4°C. Then
3x 10 min washing steps with PBST followed, before
secondary antibodies (HRP conjugated anti-mouse for
occludin, claudin1, P-gp and HRP conjugated anti-rat for
Mrp1 and Mrp4) were added in a 1:5.000 dilution and
incubated for 2 h at room temperature. Visualization of
proteins was performed with Western Lightning® PLUS
ECL and bands were detected by QuantiOne Software
with Molecular Imager ChemiDoc XRS System.
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For transport assays collagen-coated 96 well plates were
seeded with a density of 2x10
4 cells per well and cul-
tured for 4-5 days. Preliminary to the experiment, cells
were washed with PBS twice. In uptake assays cells were
pre-incubated with or without (control) inhibitors for
30 min at 37°C. All substances were dissolved in
DMSO. Final DMSO concentration in incubation solu-
tions was < 1%. Incubation with substrates and inhibi-
tors was carried out for 90 min at 37°C. Subsequently,
cells were washed with ice-cold PBS for at least three
times to determinate transport and lysed with 1% Triton
X100 in PBS for 1 h at 60°C. Analyses were performed
either by fluorescent plate reader (Ascent Fluoroscan) or
Scintillator (Packard Tri-Carb Liquid Scintillation Coun-
ter). Blank measurement was performed with cells trea-
ted only with PBS and 1% Triton X100.
Trans-epithelial electrical resistance (TEER) measurement
To determinate the influence of hydrocortisone and
dexamethasone on electrical resistance, cells were grown
on collagen-precoated transwell® polyester membranes
and treated with hydrocortisone (100nM and 550nm) in
serum-free medium for 4 days according to [29] or dex-
amethasone 1 μM for 8 days according to [25]. CellZ-
scope® (NanoAnalytics, Münster, Germany) was used for
TEER measurement.
Electron microscopy
Cells were seeded in flasks and treated with hydrocorti-
sone and dexamethasone as described above. After 4 or 8
days in culture, cells were incubated with 2.5% glutaralde-
hyde for 4 h and washed with PBS twice. Freeze-fracturing
was performed after fixation of the cells in 2.5% glutaral-
dehyde buffered with 0.1 M cacodylate buffer (pH 7.4) for
2 h at RT. Then the cells were scraped off from the sub-
strate and impregnated with 30% glycerol in cacodylate
b u f f e rf o r3 0m i n ,s h o c k - f r o z e ni nn i t r o g e ns l u s h ,t r a n s -
ferred into a Balzers freeze-fracturing device BAF 400 D
(Balzers, Liechtenstein), fractured at about 10
-6mbar and
-150°C, and shadowed with platinum/carbon (2.5nm, 45°)
and carbon (25nm, 90°). The replicas were cleaned in 13%
sodium hypochlorite, washed several times in distilled
water, mounted on Pioloform-coated copper grids and
observed in a Zeiss EM10 electron microscope (Zeiss,
Oberkochen, Germany). Photographic negatives were digi-
tized and images were arranged in Adobe Photoshop.
Statistical analysis
Presented data are means ± SE with n ≥ 3. For statistical
analyses of uptake assays unpaired student’st - t e s t
(Prism4.0 GraphPad software) was used (P values < 0.05 *,
< 0.01 **, < 0.001***).
Results
RNA expression of transport proteins quantified by real
time PCR
Comparison of transporter expression on RNA level in
freshly isolated CP with primary rat CP epithelial cells
and immortalized cell lines was performed by qPCR.
We confirmed expression of transporters previously
described in rat CP: Abcc1, 4 and 5 (Mrp1, 4 and 5) as
well as Slc22a7, 8 (Oat 2, 3) and Slco 1a4, 1a5, 2b1 and
Abcb1 (P-gp) (fig. 1A). Primary cells as well as immorta-
lized cell lines show a similar expression profile of Abc
transporters with an overall lower expression than in CP
tissue, but absent expression of Slc transporters (fig. 1B-
D). Expression of Abcc1, 4 and 5 as well as Abcb1 was
slightly higher in primary cells compared to immorta-
lized cell lines. In the TR-CSFB cell line Abcc2 (Mrp2)
RNA was expressed, but could not be detected in rat
CP, primary rat CP epithelial cells and Z310 cells. In
contrast to a previous study [19]; Slco1a5 expression
could not be detected in the TR-CSFB cell line.
Graphs in fig. 1A-D show the expression levels in CP
and cells as values according to 2
ΔCq
GAPDH
-ΔCq
GOI.F i g .
1E displays an overview of the relative expression in
cells compared to RNA expression in freshly isolated
CP. Some transporters seem to be up-regulated in
cells, including Abcc3 (Mrp3) and Abcg2 (Bcrp), but
overall their expression is still hardly detectable (fig.
1B-D). Abcc5 (Mrp5) and Abcb1 (P-gp) are higher
expressed in primary epithelial cells compared to
freshly isolated CP.
Expression of Mrp1, 4 and P-gp at the protein level
Membrane proteins were isolated from the cell lines,
while whole protein was used from rat CP, because, due
to its small size, membrane isolation was not possible.
CP tissue functioned as a positive control, Protein
expression was not visualized in primary cells because
we wanted to concentrate on characterization of the two
immortalized cell lines. Abc transporters which showed
expression at the RNA level in the cell lines were inves-
tigated for proteins expression. Mrp1, 4 and P-gp pro-
teins were found in all three samples (fig. 2), and
therefore further investigated for functional activity.
Mrp5 could not be detected in the cell lines, only in
freshly isolated CP (data not shown), therefore we did
not consider Mrp5 to be relevant in the uptake studies
of Mrp4. Mrp2 that was expressed at RNA level in TR-
CSFB cells could not be detected at the protein level
(data not shown).
Uptake Assays
I no r d e rt od i s c o v e rw h e t h e rT R - C S F Bo rZ 3 1 0c e l l
lines can be used for analysis of transport protein
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Page 4 of 12Figure 1 A-D: Relative expression of the Abc and Slc transporters is shown as mean ± SEM in isolated CP, primary CP cells and in the
immortalized cell lines TR-CSFB and Z310. Cq (quantification cycle) values for each gene were normalized to Cq values of the reference gene
Gapdh. Slco1a5 (Oatp1a5) is the most highly expressed gene in CP and shown in the separate graph. Abcb1 (P-gp), Abcc1 (Mrp1) and Abcc4
(Mrp4) are highly expressed in all cells as well as in the tissue control, while Slc genes are neither expressed in primary cells nor in the cell lines.
E: Comparison of transporter expression in the cells with expression in CP tissue, which was set to 1. Most transporters are down-regulated in
the cells. Abcc2 (Mrp2) is only expressed in TR-CSFB cells while primary cells express more Abcc5 (Mrp5) and Abcb1 (P-gp) than freshly isolated
CP. Abcc3 (Mrp3) and Abcg2 (Bcrp), which seem to be up-regulated are hardly expressed as can be seen in B-D.
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cein-AM, CellTracker™Green CMFDA and bis-POM-
PMEA. Calcein AM diffuses inside the cell where
intercellular esterases cleave the substance and fluores-
cent Calcein remains inside the cell or as a substrate
of P-gp or of Mrp1, is effluxed by those transporters.
Therefore, functional activity of P-gp and Mrp1 was
confirmed by Calcein AM uptake assay in presence of
the P-gp specific inhibitor PSC833 and Mrp specific
inhibitor MK571 (fig. 3A, B, ** = significantly different
from control, P < 0.01, *** = significantly different
from control, P < 0.001). CellTracker™Green CMFDA
(5-chloromethylfluorescein diacetate), a substrate of
M r p 1w a su s e dt of u r t h e rc o n f i r mM r p 1f u n c t i o n a l
activity. MK571 showed a strong inhibitory effect and
concentration dependency. In addition, PSC833
showed an inhibitory effect on CMFDA efflux leading
to elevated fluorescence levels inside the cells (fig. 3C,
D, *** = significantly different from control, P <0 . 0 0 1 ) .
A cumulative effect of MK571 and PSC833 could be
demonstrated for both uptake assays, accumulation is
stronger in CMFDA compared to Calcein AM assay
(fig. 3A-D).
[
3H]bis(pivaloyloxymethyl)-9-[2-(phosphonomethoxy)
ethyl]-adenine (bis-POM-PMEA), an acyclic nucleoside
phosphonate and substrate of Mrp4 was used to investi-
gate Mrp4 activity. Uptake was increased in presence of
sulindac sulfide, dipyridamole, TC (taurocholate),
DHEAS (dehydroepiandrosterone), PSC833 and MK571
for both cell lines (fig. 3E, F, *=significantly different
from control, P < 0.05, ** = significantly different from
control, P < 0.01, *** = significantly different from con-
trol, P < 0.001), presumably by inhibition of Mrp4
mediated efflux. Further, bis-POM-PMEA was used as
an inhibitor in Calcein AM and CMFDA assay and
demonstrated no inhibitory influence on Mrp1 and P-
gp, suggesting Mrp4 not to be involved in transport of
these two substances (data not shown).
Tight junction expression on RNA and protein level
Models of the BSCFB should reflect barrier properties
and the formation of TJ is critical to achieve this.
Untreated cell lines showed low or absent expression of
the TJ proteins claudin1, 2, 11 and occludin (Table 1).
In TR-CSFB cells, RNA expression of claudin 1, 2 and
occludin was up-regulated after 8 days of treatment with
1 μM dexamethasone. Occludin expression was elevated
after treating cells with hydrocortisone. Z310 cells trea-
ted with 550nM hydrocortisone displayed the highest
RNA expression of claudin 1, 2 and occludin. Compared
to freshly isolated rat CP, TJ RNA expression was 10-
100 times lower in cell lines. Primary cells showed a
somewhat higher expression, but were not comparable
to freshly isolated tissue (table 1). To verify whether TJ
proteins are expressed in the immortalized cell lines and
expression may be up-regulated after dexamthasone or
hydrocortisone treatment, western blot analyses were
performed. At protein level TR-CSFB cells revealed
higher expression of occludin after treatment with dexa-
methasone and hydrocortisone (fig. 4). In Z310 cells
expression of occludin and claudin1 was up-regulated
after hydrocortisone and dexamethasone treatment.
Overall the increase in expression of claudin1 and
occludin proteins was higher in Z310 than in TR-CSFB
cells (fig. 4).
TEER measurement in TR-CSFB and Z310
Corticosteroid treated and untreated cells of both cell
lines resulted in similar, low TEER values of 30-
40 Ωcm
2 with no tendency of elevation after treatment.
Primary cells also showed TEER values of about
30 Ωcm
2 (fig. 5).
Visualization of TJs under electron microscope
In order to verify the actual formation of tight junctions
rather than the expression of single proteins, cells were
treated with hydrocortisone and dexamethasone and
Figure 2 Western blot analyses indicate expression of Mrp1, 4 and P-gp. Whole protein was used from freshly isolated CP and membrane
vesicles were isolated from cells (20 μg). There are slight differences in protein size possibly due to modifications in tissue and cells during
processing.
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Page 6 of 12Figure 3 A, B: Calcein-AM uptake assays show concentration-dependent inhibition by PSC833, MK571 and a cumulative effect of
PSC833 and MK571. Control was set to 1. C, D: CMFDA uptake assays show strong inhibition by MK571 and also moderate inhibition by
PSC833. Again an additive effect by combination of PSC833 and MK571 is observed. *=significantly different from control, P < 0.05, ** =
significantly different from control, P < 0.01, *** = significantly different from control, P < 0.001. E, F: Uptake of [
3H]bis-POM-PMEA into TR-CSFB
cells (E) and Z310 cells (F), respectively, was enhanced by sulindac sulfide, MK571, dipyridamole, TC (taurocholate), DHEAS
(Dehydroepiandrosterone) and PSC833 acting as inhibitors of Mrp4 mediated efflux. A, C and E show TR-CSFB cells, B, D and F show Z310 cells.
*=significantly different from control, P < 0.05, ** = significantly different from control, P < 0.01, *** = significantly different from control,
P < 0.001.
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analysis. TJ formation could not be verified by this
method.
Neither the untreated TR-CSFB nor Z310 cells
showed any tight junctions in the freeze-fracture replica.
In addition, the TR-CSFB cells did not react on hydro-
cortisone treatment with appearance of tight junctions
(data not shown). However, dexamethasone treatment
was answered by rare but consistent formation of tight
junction networks associated predominantly with the
P-face (fig. 6A). This result is consistent with the up-
regulation of tight junction proteins in this cell line by
dexamethasone (table 1, fig. 4). In contrast, and again in
accordance with the biochemical data, dexamethasone
did not increase the number of tight junctions in Z310
cells (fig. 6D), but in these cells tight junctions were
slightly induced by hydrocortisone (fig. 6B, C). However,
these tight junctions never formed continuous strands
or networks, but insulated strands which probably
would not increase the TEER. Indeed, this assumption
Table 1 RNA expression of TJ proteins occludin, claudin 1, 2 and 11
TR-CSFB Z310 primary cells CP
values shown as 2
ΔCq
GAPDH -
ΔCq
GOI ×1 0
3
Average SE Average SE Average SE Average SE
claudin1 untreated 0.017 0.006 0.017 0.003 13.024 2.220 67.913 1.077
claudin1 100nM HC 0.346 0.070 2.521 0.121
claudin1 550nM HC 0.478 0.053 3.743 0.422
claudin1 1 μM Dex 2.610 0.124 1.424 0.135
claudin2 untreated 1.907 0.699 0.203 0.090 3.566 0.329 364.891 59.225
claudin2 100nM HC 0.417 0.161 3.976 0.068
claudin2 550nM HC 0.450 0.186 6.635 0.661
claudin2 1 μM Dex 4.686 1.715 0.965 0.302
claudin11 untreated 0.326 0.066 0.051 0.012 5.112 2.717 3.215 0.682
claudin11 100nM HC 0.042 0.014 0.103 0.019
claudin11 550nM HC 0.067 0.030 0.119 0.025
claudin11 1 μM Dex 0.427 0.280 0.054 0.009
occludin untreated 0.130 0.067 3.002 1.120 15.652 5.865 72.499 6.147
occludin 100nM HC 6.580 1.181 34.882 3.896
occludin 550nM HC 4.943 1.237 37.174 4.639
occludin 1 μM Dex 7.899 1.286 17.922 4.243
mRNA expression of the CP TJ proteins claudin1, 2, 11 and occludin in TR-CSFB and Z310 cells comparing untreated cells with 100nM, 550nM hydrocortisone
and 1 μM dexamethasone treated cells as well as with primary cells and CP tissue. Cq values were normalized to the reference gene GAPDH according to
2
ΔCq
GAPDH
-ΔCq
GOI and multiplied with 10
3 for better readable format (values in table). Bold values indicate high or elevated RNA expression. Claudin1 and claudin2
were highly up-regulated in TR-CSFB cells after treatment with dexamethasone, while hydrocortisone treatment had a higher impact on claudin1 and 2 RNA
expression in Z310 cells. Occludin on the other hand was up-regulated by all corticosteroid treatments, but again dexamethasone had a higher impact on its
expression in TR-CSFB, while hydrocortisone elevated occludin expression in Z310 twice as much as dexamethasone.
Figure 4 Western blots with anti-occludin antibodies and anti-claudin-1 show higher expression of the two TJ proteins in Z310
compared to TR-CSFB cells and slightly increasing expression after treatment with glucocorticoids, dexamethasone (Dexa) and
hydrocortisone (HC).2 0μg of each protein were applied. Occludin shows 2 bands, representing the phosphorylated momomeric subunit at
65kD and the unphosphorylated subunit at 51 kD. After detection of occludin and claudin-1, blots were stripped and Na/K-ATPase was detected.
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low after treatment with hydrocortisone or dexametha-
sone (fig. 5)
Discussion
In this study expression of the major known CP ABC
transporters Abcc1 (Mrp1), Abcc4 (Mrp4) and Abcc5
(Mrp5) could be confirmed at the RNA level in freshly
isolated tissue as well as in primary cell culture and the
immortalized cell lines TR-CSFB and Z310. Compared
with the RNA expression profile of CP transporters
from Choudhuri et al. in 2003 [7], we found Abcc trans-
porters to be expressed in a very similar ratio. Abcc1
and Abcc4 display a 4 to 5 time higher expression than
Abcc5 in Choudhuri’s studies, whereas our profile indi-
cates a 7-8 times higher expression. Slco1a5 has been
shown to be the most highly expressed gene in both stu-
dies, whereas Slco1a4 and 1b2 seem to have very low
expression. Slc22a7 and 8 are both expressed, but in our
profile Slc22a7 is about half of the expression of
Slc22a8 (fig. 1A), in Choudhuri’s profile it is 3% of
Slc22a8. The major difference of the two profiles is the
expression of P-gp, which is very high in our study and
very low in the other. The differences in the two expres-
sion profiles might be due to strain differences or gen-
der-dependent deviations. In our study we used only
male Wistar rats (230-250g) while Choudhuri et al. used
both genders of Sprague- Dawley rats (150-200 g). Also
primer specificity and method variations might have
influenced the outcomes. In our work, we used qPCR,
while Choudhuri et al. performed the expression profiles
with the branched DNA assay method, which is based
on hybridization not replication and no RT-PCR is
needed to produce cDNA.
The two cell lines show a very similar expression pro-
file with minor differences like RNA expression of
Abcc2 in TR-CSFB cells (fig. 1C). Slc transporters that
are present in CP could be confirmed neither in primary
rat CP epithelial cells nor in the cell line models. The
loss of those transporters might be due to the cell isola-
tion process or conditions in the growth media. It has
been shown that immortalization with SV40 large T
antigen can lead to an increase of cytokines like IL-1
[30], which was demonstrated to down-regulate expres-
sion of hepatic organic anion transporters [31]. Taking a
closer look into the pathway regulation of Slc expression
might reveal the reason. A controversial result concern-
ing Oatp1a5 was published by Ohtsuki [21] who found
Slco1a5 to have very low expression at the RNA level
a n dc o u l dc o n f i r mi t sa c t i v i ty by esterone-3-sulfate
transport. Since the same cells were used at lower pas-
sage numbers (P51-P54) compared to our experiments
(P67-P73), there might be a loss of expression in this
cell line over time [32].
The controversial Abc transporter P-gp has been
shown to be present in rat CP before [5] and to be
expressed but not functionally active in porcine CP [33].
Choudhuri et al. 2003 [7] on the other hand found very
low Abcb1 RNA expression in rat CP. Our findings
demonstrated expression in freshly isolated rat CP and
cell lines at the RNA (fig. 1) and protein level (fig. 2). In
addition Calcein AM assay in TR-CSFB and Z310
showed significant inhibition by the P-gp specific inhibi-
tor PSC883 (fig. 1A, B). Calcein-AM assay also revealed
inhibition by Mrp1 inhibitor MK571 (fig. 3A, B), which
might confirm Mrp1 activity, because Calcein AM is
also transported by Mrp1 [34]. CellTracker™Green
CMFDA, a substrate of Mrp1 and 2 [35] was used to
further confirm Mrp1 functionality. Since Mrp2 was not
expressed at the protein level it could be neglected.
MK571 showed a strong inhibitory effect in the
CMFDA assay, PSC833 treatment also led to increased
intracellular fluorescence, but to a lower extent (fig. 3C,
D). A combination of both inhibitors led to cumulated
effects, which leads to the assumption that both, P-gp
and Mrp1, actively participate in transport of Calcein
and CMFDA, respectively. The Mrp4 substrate [
3H]bis-
POM-PMEA (fig. 3E, F) diffuses into cells [11] and
uptake was inhibited by Mrp4 inhibitors sulindac sulfide,
dipyridamole, taurocholate, DHEAS and MK571 [12,36].
Figure 5 Trans-endothelial electrical resistance (TEER) values of
TR-CSFB and Z310 cells treated with 100nM and 550nM
hydrocortisone measured in serum- free medium for 4 days or
1 μM dexamethasone for 8 days. Untreated primary cells were
used as control. Overall untreated and treated cells were grown
on collagen-precoated transwell® polyester membrane plates for
14 days.
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3H]bis-
P O M - P M E A .I th a sb e e np u b l i s h e dt h a tP - g pd o e sn o t
transport [
3H]bis-POM-PMEA [37]. In order to confirm
that bis-POM-PMEA has no influence on P-gp and
Mrp1 transport, it was used as an inhibitor in Calcein
AM and CMFDA assays, where it showed no influence
up to 10 μM ,p o i n t i n go u tt h a tP S C 8 3 3i n d e e di n h i b i t s
Mrp4 activity (data not shown). Taken together the
results indicate that the inhibition by MK571, taurocho-
late, DHEAS, sulindac sulfide and dipyridamole is due
to active efflux transport of [
3H]bis-POM-PMEA via
Mrp4.
Tight junction expression and formation under the
influence of corticosteroids
TEER values found in primary porcine CP epithelial
cells revealed 100-150 Ωcm
2 [33] and in bull frog
170 Ωcm
2 [38]. In primary CP cells, TEER was 70-
178 Ωcm
2 [4,26,39] and was found to be highest after
8 DIC. For Z310 cells, TEER values of 50-200 Ωcm
2
[4,25] were measured, while for TR-CSFB cells the value
was about 50 Ωcm
2 [3]. Zheng et al.f u r t h e r m o r e ,c o n -
firmed lower [
14C] sucrose permeability after treatment
with 1 μM dexamethasone for Z310 cells, accompanied
by up to 50% higher TEER values [25]. The influence of
corticosteroids and serum-free medium on tightness of
porcine CPEC monolayer was reported before [40], but
could not be confirmed for the immortalized cell lines.
We found TEER values of 30-40 Ωcm
2 for both cell
lines as well as for primary cells using cellZscope® mea-
surement and no elevation of TEER values after treat-
ment with hydrocortisone or dexamethasone in the cell
lines (fig. 5). Our lower TEER values received for cell
lines as well as for primary cells might be due to differ-
ent measurement methods using cellZscope® analyses in
our study (for a detailed comparison of chopstick vs.
cellZscope® measurements, the reader can refer to
http://www.nanoanalytics.com).
Figure 6 Freeze-fracture replicas from TR-CSFB cells (A) and Z310 cells (B-D) treated with 1 μM dexamethsone (dexa. A, D) and 100
nM (B) and 550nM (C) hydrocortisone (HC). Whereas the TR-CSFB cells (A), but not the Z310 cells (D), have been partly induced by
dexamethasone to form tight junctions (TJs), the Z310 cells (B,C), but not the TR-CSFB cells (not shown), can be induced by hydrocortisone to
form some TJs. Arrows point to TJs particles in all pictures. EF: external fracture face, PF: protoplasmic fracture face.
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microscopical freeze-fracture analysis, where TJs could
be found only rarely after hydrocortisone and dexa-
methasone treatment (fig. 6). However, in no instance
did tight junctions induced by the treatments (fig. 6),
show an increase the TEER (fig. 5). Z310 cells revealed
an overall higher expression profile than TR-CSFB cells
which goes along with the lower TEER values
(50 Ωcm
2) that were published for TR-CSFB cells [3],
b u tw ec o u l dn o td e t e c ta n yd i f f e r e n c e sb e t w e e nT R -
CSFB and Z310 cells in TEER nor in the appearance of
tight junctions.
As stated above the elevated tight junction protein
expression did not lead to the actual formation of TJs.
Since other proteins like Junctional Adhesion Molecules
(JAMs), Crumb (Crb) and a number of cytoplasmic per-
ipheral proteins are also involved in the pathway of TJ
formation the whole pathway would need to be investi-
gated to find the reason why TJ are not formed in the
cell models. Transfection with SV40 large T antigen
might have an influence on the pathway [41].
Conclusion
Our results lead to the suggestion that the immortalized
cell lines have to be used carefully and transport data have
to be interpreted cautiously, as the expression of transport
proteins does not exactly reflect the in vivo situation.
Nevertheless, these cell lines might be particularly helpful
to study transport processes at the blood-cerebrospinal
fluid barrier mediated by Mrp1, Mrp4 or P-gp.
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